Literature DB >> 1116653

Clinical and epidemiological significance of the HBSAg (Australia antigen): carrier state.

S V Feinman, N Cooter, J C Sinclair, D M Wobel, B Berris.   

Abstract

One hundred fifteen asymptomatic Australia antigen (HBSAg) carriers, discovered by routine testing of volunteer blood donors in Toronto, were investigated and followed for up to 30 months. The carrier state seems to be largely host-dependent, and its prevalence is modified by ethnic origin, sex, and age. A high prevalence of carriers was found in persons coming from Mediterranean countries and the Orient. The carrier state was 3 times more common in males than in females, and the majority of the carriers were under 30 years of age. Family clustering of HBSAg-positive individuals was observed. All carriers were asymptomatic and only one gave a history of jaundice in the past. Seven gave a history of intravenous drug use. Four had moderate hepatomegaly. Fifty-four had some abnormality in their liver function tests. The SGPT was the most frequently abnormal test and correlated best with the histological findings. Twenty of 29 liver biopsies showed features of chronic benign persisting hepatitis. All patients remained well during the follow-up period. In no patient was there evidence of deterioration or progression in either their clinical state, liver function, or pathological findings. Only 1 of the 115 carriers became HBSAg-negative over the period of observation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1116653

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Serial liver biopsy observations in hepatitis B antigen carriers by light and electron microscopy.

Authors:  S Sun; R P Beasley; K E Anderson; H S Berg; C Hsu; W Lee
Journal:  Am J Dig Dis       Date:  1976-05

2.  Practical guidelines for assessing patients positive for hepatitis B surface antigen.

Authors:  S V Feinman; B Berris; J C Sinclair; D W Wrobel
Journal:  Can Med Assoc J       Date:  1976-11-20       Impact factor: 8.262

3.  Inability to detect hepatitis B surface antigen (HBsAg) in the duodenum of HBsAg-positive persons.

Authors:  S V Feinman; B Berris; J C Sinclair; S Wilson; D Wrobel
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

4.  Chronic carriers of hepatitis B antigen (HBsAg). Histological, biochemical, and immunological findings in 31 voluntary blood donors.

Authors:  J P Villeneuve; G Richer; J Côté; R Guévin; D Marleau; J G Joly; A Viallet
Journal:  Am J Dig Dis       Date:  1976-01

5.  Viral hepatitis: new aspects of an old disease.

Authors:  S V Feinman
Journal:  Can Fam Physician       Date:  1976-08       Impact factor: 3.275

Review 6.  Hepatitis B virus infection. Current concepts of chronicity and immunity.

Authors:  G N Vyas; H E Blum
Journal:  West J Med       Date:  1984-05

7.  [The characterization of clinically healthy hepatitis-b-surface-antigen (HBsAg)-carriers. Clinical, biochemical, histiological and immunological investigations in 129 case of a prospective study (author's transl)].

Authors:  J Knolle; M Born; G Hess; O Klinge; W Arnold; H Bitz; K H Meyer
Journal:  Klin Wochenschr       Date:  1976-06-15

8.  Chemical liver function tests and epidemiologic studies of HBsAg positive blood donors.

Authors:  Y C Kim; J S Kim; S H Kim; S M Lee; W B Shim; H K Moon
Journal:  Korean J Intern Med       Date:  1986-01       Impact factor: 2.884

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.